Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

West Pharma earnings show it's more than a GLP-1 play. Why we see more upside

Summary by CNBC
Since CNBC highlighted the stock's attractive valuation in August, shares have gained around 20%. Why we expect more upside ahead.

1 Articles

CNBCCNBC
Center

West Pharma earnings show it's more than a GLP-1 play. Why we see more upside

Since CNBC highlighted the stock's attractive valuation in August, shares have gained around 20%. Why we expect more upside ahead.

·Englewood Cliffs, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

CNBC broke the news in Englewood Cliffs, United States on Thursday, October 29, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Stock Markets icon

Stock Markets

GLP-1 icon

GLP-1

Exton, Pennsylvania icon

Exton, Pennsylvania

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal